Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

R-CVP Chemoimmunotherapy for Limited-Stage Ocular Adnexal MALT Lymphoma with Adverse Factors: A Phase II Study

Sung-Yong Kim, MD, Seok-Goo Cho, Won-Sik Lee, MD, Suk-Woo Yang, MD, Sung Yong Oh, MD, Hee Bae Ahn, MD, Deok-Hwan Yang, Seong Kyu Park, Jee Ho Chang, MD, Hyo Jung Kim, MD PhD, Min Joung Lee, Jae Wook Yang

Blood (2016) 128 (22): 2981.

https://doi.org/10.1182/blood.V128.22.2981.2981

Published: 2016

Journal Articles

A Phase I Study of Idarubicin Dose Escalation for Remission Induction Therapy in Acute Myeloid Leukemia

Mark Lee, MD PhD, Sung-Yong Kim, MD

Blood (2015) 126 (23): 1344.

https://doi.org/10.1182/blood.V126.23.1344.1344

Published: 2015

Journal Articles

Lenalidomide As a Second-Line Therapy after Failure of Hypomethylating Agents in Patients with Myelodysplastic Syndrome

Hawk Kim, MD PhD, Je-Hwan Lee, MD PhD, Won-Sik Lee, MD, Inho Kim, Joon Ho Moon, MD, PhD, Chul Won Choi, MD PhD, Ho Sup Lee, MD PhD, Jinny Park, Ho-Jin Shin, Kyoung Ha Kim, MD, Su-Hee Cho, MD PhD, Sung-Yong Kim, MD, Yoo-Jin Kim

Blood (2015) 126 (23): 1687.

https://doi.org/10.1182/blood.V126.23.1687.1687

Published: 2015

Journal Articles

What Can We Do for the Unrelated Donors of Hematopoietic Stem Cell to Lessen Their Agony?

Mark Lee, MD PhD, Jung Hwa Na, R.N., Hyung In Jang, R.N., Jin Ho Jang, R.N., Jongchan Lee, PhD, Chuhl Joo Lyu, MD PhD, Sung-Yong Kim, MD

Blood (2014) 124 (21): 5832.

https://doi.org/10.1182/blood.V124.21.5832.5832

Published: 2014

Journal Articles

Transplantation For Myelodysplastic Syndrome Evolving From Aplastic Anemia Treated With Immunosuppressive Therapy: From The Fred Hutchinson Cancer Research Center and Center For International Bone Marrow Transplantation Research

Sung-Yong Kim, MD, Jennifer Le Rademacher, PhD, Jeanette Carreras, MPH, Joseph H. Antin, MD, Paolo Anderlini, MD, Mouhab Ayas, MD, Minoo Battiwalla, MD, MS, Joanne Kurtzberg, MD, Ryotaro Nakamura, MD, Mary Eapen, MBBS, MS, H. Joachim Deeg, MD

Blood (2013) 122 (21): 924.

https://doi.org/10.1182/blood.V122.21.924.924

Published: 2013

Journal Articles

Characteristics and Clinical Outcomes of Adult Aplastic Anemia with Abnormal Cytogenetics at Diagnosis.

Sung-Yong Kim, MD., Myungshin Kim, MD, PhD, Kyungja Han, MD, PhD, Seok Lee, MD, PhD, Mark Hong Lee, MD, PhD, Jong-Wook Lee, MD, PhD, Woo-Sung Min, MD, PhD, Chun-Choo Kim, MD, PhD

Blood (2008) 112 (11): 2039.

https://doi.org/10.1182/blood.V112.11.2039.2039

Published: 2008

Journal Articles

Deferasirox Might Induce Immunosuppression Comparable to Deferoxamine.

Dae-Chul Jeong, MD, Nack-Gyun Chung, MD, Bin Cho, MD, Sung-Yong Kim, MD, Chi Wha Han, MD, Hack Ki Kim, MD

Blood (2007) 110 (11): 3755.

https://doi.org/10.1182/blood.V110.11.3755.3755

Published: 2007

Journal Articles

Predictive Potential of Minimal Residual Disease Level after the First Imatinib Cycle on the Outcome of Allogeneic Stem Cell Transplantation in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Seok Lee, MD, Yoo-Jin Kim, MD, Chang-Ki Min, MD, Byung-Sik Cho, MD, Sung-Yong Kim, MD, Ki-Seong Eom, MD, Heeje Kim, MD, Seok-Goo Cho, MD, Dong-Wook Kim, MD, Jong-Wook Lee, MD, Woo-Sung Min, MD, Chun-Choo Kim, MD

Blood (2007) 110 (11): 1098.

https://doi.org/10.1182/blood.V110.11.1098.1098

Published: 2007

Journal Articles

Overcoming Graft Rejection in Adult Patients with High-Risk Severe Aplastic Anemia Using Supplemental CD34 + -Enriched PBSC in Combination with BM.

Byung-Sik Cho, MD, Sung-Yong Kim, MD, Yoo-Jin Kim, MD, Ki-Seong Eom, MD, Hee-Je Kim, MD, Seok Lee, MD, Chang-Ki Min, MD, Dong-Wook Kim, MD, Jong-Wook Lee, MD, Woo-Sung Min, MD, Chun-Choo Kim, MD

Blood (2007) 110 (11): 1111.

https://doi.org/10.1182/blood.V110.11.1111.1111

Published: 2007

Journal Articles

Comparative 2-Arm Study for Acute Graft-Versus-Host Disease; Antithymocyte Globulin Is More Effective Than Mycofenolate Mofetil on Outcome of Allogeneic Peripheral Blood Stem Cell Transplantation from Mismatched Unrelated Donors.

Woo-Sung Min, MD, PhD, Heeje Kim, MD, PhD, Byoung-Sik Cho, MD, Sung-Yong Kim, MD, Ki-Sung Eom, MD, Chang-Ki Min, MD, PhD, Seok Lee, MD, PhD, Jong-Wook Lee, MD, PhD, Chong-Won Park, MD, PhD, Chun-Choo Kim, MD, PhD

Blood (2006) 108 (11): 5395.

https://doi.org/10.1182/blood.V108.11.5395.5395

Published: 2006

Journal Articles

Inflammatory Events in Early Posttransplantation Period Are Associated with the Relapse Kinetics of Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation.

Sung-Yong Kim, MD, Chang-Ki Min, M.D., Mi-Jin Lee, M.D., Byung-Sik Cho, M.D., Ki-Seong Eom, M.D., Yoo-Jin Kim, M.D., Seok Lee, M.D., Hee-Je Kim, M.D., Seok-Goo Cho, M.D., Dong-Wook Kim, M.D., Jong-Wook Lee, M.D., Woo-Sung Min, M.D., Jong-Won Park, M.D., Chun-Choo Kim, M.D.

Blood (2006) 108 (11): 5334.

https://doi.org/10.1182/blood.V108.11.5334.5334

Published: 2006

Journal Articles

Gemtuzumab Ozogamicin in Combination with Attenuated Dose of Standard Induction Chemotherapy Therapy Can Successfully Induce Complete Remission without Increasing Toxicity in Patients with Newly Diagnosed Acute Myeloid Leukemia Aged 55 or Older.

Ki-Seong Eom, MD, Hee-Je Kim, MD, Chang-Ki Min, MD, Seok Lee, MD, Sung-Yong Kim, MD, Byung-Sik Cho, MD, Seok-Goo Cho, MD, Dong-Wook Kim, MD, Jong-Wook Lee, MD, Woo-Sung Min, MD, Chong-Won Park, MD, Chun-Choo Kim, MD

Blood (2006) 108 (11): 1982.

https://doi.org/10.1182/blood.V108.11.1982.1982

Published: 2006

Journal Articles

Allogeneic Stem Cell Transplantation Should Be Performed in First Complete Remission in Adults with Acute Lymphoblastic Leukemia; Strong Antileukemic Activity of Chronic Graft-Versus-Host Disease.

Seok Lee, MD, Byung-Shik Cho, MD, Sung-Yong Kim, MD, Ki-Seong Eom, MD, Yoo-Jin Kim, MD, Chang-Ki Min, MD, Hee-Je Kim, MD, Seok-Goo Cho, MD, Dong-Wook Kim, MD, Jong-Wook Lee, MD, Woo-Sung Min, MD, Jong-Won Park, MD, Chun-Choo Kim, MD

Blood (2006) 108 (11): 2992.

https://doi.org/10.1182/blood.V108.11.2992.2992

Published: 2006

Journal Articles

Clinical Implications of Abnormal Cytogenetics at Diagnosis of Aplastic Anemia.

Sung-Yong Kim, MD, Jong-Wook Lee, M.D., Byung-Sik Cho, M.D., Ki-Seong Eom, M.D., Yoo-Jin Kim, M.D., Seok Lee, M.D., Chang-Ki Min, M.D., Hee-Je Kim, M.D., Seok-Goo Cho, M.D., Dong-Wook Kim, M.D., Woo-Sung Min, M.D., Chun-Choo Kim, M.D.

Blood (2006) 108 (11): 986.

https://doi.org/10.1182/blood.V108.11.986.986

Published: 2006

Journal Articles

High Level of Pretransplant Leukemic Blasts and the Absence of Chronic Graft-Versus-Host Disease Provide Negative Effects on Clinical Outcome of Transplantation with Fludarabine-Busulfex Based Reduced Intensity Conditioning for Patients with the De Novo Myelodysplastic Syndrome According to WHO Criteria.

Seok-Goo Cho, MD, PhD, Byung-Sik Cho, MD, Yoo-Jin Kim, MD, PhD, Sung-Yong Kim, MD, PhD, Ki-Seong Eom, MD, PhD, HeeJe Kim, MD, PhD, Seok Lee, MD, PhD, Chang-Ki Min, MD, PhD, Dong-Wook Kim, MD, PhD, Jong-Wook Lee, MD, PhD, Woo-Sung Min, MD, PhD, Chun-Choo Kim, MD, PhD

Blood (2006) 108 (11): 4862.

https://doi.org/10.1182/blood.V108.11.4862.4862

Published: 2006

Journal Articles

Outcome of Allogeneic Stem Cell Transplantation for Patients with Severe Aplastic Anemia after Conditioning with Procarbazine, ATG and Cyclophosphamide: A Single Center Experience.

Ki Seong, Eom, MD, Jong Wook Lee, MD, Yoo Jin Kim, MD, Hee Je Kim, MD, Chang Ki, Min, MD, Seok Lee, MD, Sung Yong, Kim, MD, Woo Sung, Min, MD, Chun Choo Kim, MD

Blood (2005) 106 (11): 2027.

https://doi.org/10.1182/blood.V106.11.2027.2027

Published: 2005

Journal Articles

Expression of CD25+ Cell Subsets after Induction Chemotherapy in Adult Patients with Acute Myeloid Leukemia.

Woo-Sung Min, MD, PhD, Hee-Je Kim, MD, PhD, Young Choi, MD, PhD, Sung-Yong Kim, MD, Ki-Sung Eom, MD, Yoo-Jin Kim, MD, PhD, Seok Lee, MD, PhD, Chang-Ki Min, MD, PhD, Jong-Wook Lee, MD, PhD, Chun-Choo Kim, MD, PhD

Blood (2005) 106 (11): 4597.

https://doi.org/10.1182/blood.V106.11.4597.4597

Published: 2005

NARROW

R-CVP Chemoimmunotherapy for Limited-Stage Ocular Adnexal MALT Lymphoma with Adverse Factors: A Phase II Study

A Phase I Study of Idarubicin Dose Escalation for Remission Induction Therapy in Acute Myeloid Leukemia

Lenalidomide As a Second-Line Therapy after Failure of Hypomethylating Agents in Patients with Myelodysplastic Syndrome

What Can We Do for the Unrelated Donors of Hematopoietic Stem Cell to Lessen Their Agony?

Transplantation For Myelodysplastic Syndrome Evolving From Aplastic Anemia Treated With Immunosuppressive Therapy: From The Fred Hutchinson Cancer Research Center and Center For International Bone Marrow Transplantation Research

Characteristics and Clinical Outcomes of Adult Aplastic Anemia with Abnormal Cytogenetics at Diagnosis.

Deferasirox Might Induce Immunosuppression Comparable to Deferoxamine.

Predictive Potential of Minimal Residual Disease Level after the First Imatinib Cycle on the Outcome of Allogeneic Stem Cell Transplantation in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Overcoming Graft Rejection in Adult Patients with High-Risk Severe Aplastic Anemia Using Supplemental CD34 + -Enriched PBSC in Combination with BM.

Comparative 2-Arm Study for Acute Graft-Versus-Host Disease; Antithymocyte Globulin Is More Effective Than Mycofenolate Mofetil on Outcome of Allogeneic Peripheral Blood Stem Cell Transplantation from Mismatched Unrelated Donors.

Inflammatory Events in Early Posttransplantation Period Are Associated with the Relapse Kinetics of Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation.

Gemtuzumab Ozogamicin in Combination with Attenuated Dose of Standard Induction Chemotherapy Therapy Can Successfully Induce Complete Remission without Increasing Toxicity in Patients with Newly Diagnosed Acute Myeloid Leukemia Aged 55 or Older.

Allogeneic Stem Cell Transplantation Should Be Performed in First Complete Remission in Adults with Acute Lymphoblastic Leukemia; Strong Antileukemic Activity of Chronic Graft-Versus-Host Disease.

Clinical Implications of Abnormal Cytogenetics at Diagnosis of Aplastic Anemia.

Outcome of Allogeneic Stem Cell Transplantation for Patients with Severe Aplastic Anemia after Conditioning with Procarbazine, ATG and Cyclophosphamide: A Single Center Experience.

Expression of CD25+ Cell Subsets after Induction Chemotherapy in Adult Patients with Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only